APA (7th ed.) Citation

CN, D., F, R., R, R., X, Z., A, S. D., A, H., . . . K, M. (2023). CuATSM effectively ameliorates ALS patient astrocyte-mediated motor neuron toxicity in human in vitro models of amyotrophic lateral sclerosis. Glia, 71(2), 350. https://doi.org/10.1002/glia.24278

Chicago Style (17th ed.) Citation

CN, Dennys, et al. "CuATSM Effectively Ameliorates ALS Patient Astrocyte-mediated Motor Neuron Toxicity in Human in Vitro Models of Amyotrophic Lateral Sclerosis." Glia 71, no. 2 (2023): 350. https://doi.org/10.1002/glia.24278.

MLA (9th ed.) Citation

CN, Dennys, et al. "CuATSM Effectively Ameliorates ALS Patient Astrocyte-mediated Motor Neuron Toxicity in Human in Vitro Models of Amyotrophic Lateral Sclerosis." Glia, vol. 71, no. 2, 2023, p. 350, https://doi.org/10.1002/glia.24278.